Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 21:45 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.2
- Combined market value
- NOK 87.17T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | NOK 296.5B | NOK 1,960.71 | 4.45% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | NOK 173.3B | NOK 6,194.96 | 1.99% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | NOK 2.02T | NOK 1,627.25 | 1.45% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | NOK 483.1B | NOK 1,713.34 | 1.12% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | NOK 60.3B | NOK 426.53 | 1.25% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | NOK 232.7B | NOK 5,463.27 | 3.16% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.6 | NOK 103.7B | NOK 909.14 | 2.88% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | NOK 4.9T | NOK 2,770.62 | 0.86% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | NOK 331.5B | NOK 16,666.92 | 1.82% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | NOK 309.4B | NOK 501.77 | 0.75% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.5 | NOK 446.1B | NOK 3,905.68 | 0.97% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | NOK 123.2B | NOK 3,126.99 | 0.18% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | NOK 270B | NOK 3,876.27 | 1.81% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | NOK 69.5B | NOK 634.95 | 4.15% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | NOK 111.6B | NOK 710.39 | 0.07% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.4 | NOK 45.3B | NOK 471.97 | 3.86% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | NOK 90.1B | NOK 3,876.76 | 0.34% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | NOK 583.7B | NOK 1,015.07 | 1.28% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | NOK 71.8B | NOK 913.98 | 1.59% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | NOK 1.29T | NOK 5,087.65 | 2.94% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | NOK 69.7B | NOK 1,325.80 | 1.25% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.7 | NOK 73.8B | NOK 560.69 | 0.54% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | NOK 60.9B | NOK 933.28 | 3.27% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | NOK 530.9B | NOK 6,738.94 | 1.26% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.0 | NOK 1.38T | NOK 3,979.36 | 3.26% down | 24% down | ||
| 126 | BillionToOneBLLN · Health Care | 14.1 | NOK 42.1B | NOK 881.39 | 1.46% down | 4% down | ||
| 127 | argenxARGX · Health Care | 14.3 | NOK 578.9B | NOK 9,205.18 | 0.08% up | 2% up | ||
| 128 | RepligenRGEN · Health Care | 14.7 | NOK 106.4B | NOK 1,664.00 | 1.38% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | NOK 95.8B | NOK 633.98 | 1.88% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | NOK 380.5B | NOK 661.73 | 1.38% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | NOK 44.4B | NOK 274.09 | 1.44% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.2 | NOK 410.8B | NOK 2,832.96 | 0.15% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | NOK 11.76T | NOK 13,202.52 | 2.29% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.1 | NOK 192.5B | NOK 1,422.64 | 0.31% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.2 | NOK 74.4B | NOK 1,090.70 | 4.07% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.0 | NOK 164.1B | NOK 2,501.12 | 5.32% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | NOK 56.1B | NOK 2,803.85 | 3.94% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.3 | NOK 38.3B | NOK 436.10 | 2.75% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.1 | NOK 91.5B | NOK 3,086.05 | 0.15% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.8 | NOK 137.7B | NOK 2,326.60 | 2.15% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.3 | NOK 876.6B | NOK 4,460.51 | 2.06% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | NOK 148.8B | NOK 763.94 | 0.22% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.0 | NOK 46.1B | NOK 1,024.45 | 2.68% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.5 | NOK 788.1B | NOK 1,947.76 | 1.29% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | NOK 79.1B | NOK 1,141.32 | 1.88% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.3 | NOK 309.7B | NOK 1,411.60 | 20.58% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.7 | NOK 68.3B | NOK 64.20 | 1.94% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.4 | NOK 70B | NOK 502.84 | 0.27% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 176 | NOK 79.1B | NOK 1,211.87 | 2.47% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 260 | NOK 99.6B | NOK 1,166.62 | 1.44% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1076 | NOK 36.9B | NOK 380.41 | 3.14% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1811 | NOK 71.5B | NOK 800.29 | 2.38% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2346 | NOK 46.7B | NOK 828.92 | 1.01% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3418 | NOK 275.8B | NOK 380.70 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7715 NOK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 21:45 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of NOK 87.17T as of 19 Nov 2026, 21:45 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.